AI-Developed Drug Rentosertib Shows Anti-Aging Hallmarks in Early Data

Early data from a trial of rentosertib, an AI-designed drug for a rare lung condition, suggests it may also reduce biological markers of aging. The findings are preliminary and based on company disclosures, with independent verification pending. If confirmed, this would mark a significant advance in both AI-driven drug discovery and longevity research.